Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen.


Journal

Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289

Informations de publication

Date de publication:
10 2020
Historique:
received: 16 06 2020
accepted: 28 07 2020
pubmed: 10 8 2020
medline: 11 11 2020
entrez: 10 8 2020
Statut: ppublish

Résumé

Chimeric antigen receptors (CARs) and their parent signaling molecule, the T cell receptor (TCR), are fascinating proteins of increasing relevance to disease therapy. Here we use a collection of 1221 pMHC-directed CAR constructs representing 10 pMHC targets to study aspects of CAR structure-activity relationships (SAR), with particular focus on the extracellular and transmembrane structural components. These experiments that involve pMHC targets whose number/cell can be manipulated by peptide dosing in vitro enable systematic analysis of the SAR of CARs in carefully controlled experimental situations (Harris and Kranz, 2016). We find that CARs tolerate a wide range of structural variation, with the ligand-binding domains (LBDs) dominating the SAR of CAR antigen sensitivity. Notwithstanding the critical role of the LBD, CAR antigen-binding on the cell surface, measured by pMHC tetramer staining, is not an effective predictor of functional sensitivity. These results have important implications for the design and testing of CARs aimed toward the clinic.

Identifiants

pubmed: 32768859
pii: S0161-5890(20)30435-1
doi: 10.1016/j.molimm.2020.07.020
pii:
doi:

Substances chimiques

HLA-A Antigens 0
Ligands 0
Receptors, Chimeric Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-64

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Han Xu (H)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Agnes E Hamburger (AE)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Jee-Young Mock (JY)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Xueyin Wang (X)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Aaron D Martin (AD)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Talar Tokatlian (T)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Julyun Oh (J)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Mark E Daris (ME)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Kathleen R Negri (KR)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Grant B Gabrelow (GB)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Ming Lun Wu (ML)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Daniel P Nampe (DP)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Grace E Asuelime (GE)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Michele E McElvain (ME)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Mark L Sandberg (ML)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States.

Alexander Kamb (A)

A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA, 91301, United States. Electronic address: akamb@a2biotherapeutics.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH